Cargando…
Pancreatitis in a 57-Year-Old Female Two Weeks After Initiation of Empagliflozin
BACKGROUND/OBJECTIVE: Pancreatitis is a common diagnosis requiring hospital admission, associated with significant costs. Although pancreatitis is an established side-effect with other diabetes medications, such as Glucagon like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase 4 inhibitors, the...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association of Clinical Endocrinology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382614/ https://www.ncbi.nlm.nih.gov/pubmed/37520757 http://dx.doi.org/10.1016/j.aace.2023.04.005 |